Nearing the end of talks with Israeli manufacturers, the Indian pharmaceutical company decided to acquire shares of the Israeli UAV manufacturer
Several days after IsraelDefense reported on India’s intentions to invest in the Israeli defense industries, it is now official – India’s pharmaceutical giant Piramal Healthcare will acquire some of the shares of the Israeli UAV manufacturer BlueBird for $20 million dollars.
IsraelDefense reported just several days ago that India is interested in investing in the Israeli defense industries, and that Piramal is conducting meetings with several Israeli manufacturers planning to approach defense tenders in India.
At the end of the talks that Piramal held with several Israeli manufacturers, the Indian company decided to acquire shares of the Israeli UAV manufacturer BlueBird. The Israeli company has refused to comment, but it seems that the final agreement will soon be signed.
The investment will apparently take place via Piramal's US subsidiary. The company plans to establish a defense subsidiary, which may lead to potential investments in additional Israeli companies.
The planned Indian tender will include 500 mini and micro UAV systems that have an endurance of at least 30 minutes and can be operated by one or two soldiers. Israel Aerospace Industries (IAI) has a strong position within the Indian defense establishment, and it will apparently offer several mini-UAV models.
BlueBird, whose shares will be acquired in part by the Indian pharmaceutical company, has already concluded a cooperation agreement with the Indian company Dynamatic.
No comments:
Post a Comment